Clinical Trials Directory

Trials / Completed

CompletedNCT01830842

Acute and Chronic Nicotine Modulation of Reinforcement Learning

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
54 (actual)
Sponsor
Duke University · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) to investigate the acute and chronic effects of nicotine on motivational behavior and prediction error-related neural activation. Nonsmokers (n = 24) and smokers (n = 24) will undergo fMRI scans on two separate occasions while performing a decision-making task that will elicit prediction error signals in the mesocorticolimbic pathway of the brain. Nonsmokers will be scanned once following an acute dose of nicotine and once following placebo administration. Smokers will be scanned once following smoking as usual and once following 24-hours of smoking abstinence, in order to measure the effects of nicotine withdrawal. The study team hypothesizes that acute nicotine will increase the prediction error signal in nonsmokers compared to placebo, and that nicotine withdrawal will decrease the prediction error signal in smokers compared to the normal satiated condition. Furthermore, nonsmokers (during the placebo condition) will have greater prediction error activation than smokers (during the satiated condition). The results of this study will inform whether the initiation and maintenance of smoking behavior could be facilitated by the effects of nicotine on reinforcement learning.

Conditions

Interventions

TypeNameDescription
DRUGNicotine polacrilexnonsmokers will be measured following nicotine administration
DRUGPlacebononsmokers will be measured following placebo administration
OTHERsatietysmokers will be measured in a smoking satiated condition
OTHERabstinencesmokers will be measured following 24-hours of smoking abstinence

Timeline

Start date
2014-02-01
Primary completion
2016-08-31
Completion
2016-08-31
First posted
2013-04-12
Last updated
2017-12-19
Results posted
2017-12-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01830842. Inclusion in this directory is not an endorsement.